Price Alert

Harmony Biosciences Inc. (HRMY)

NASDAQ: HRMY · Real-Time Price · USD

36.88

0.37 (1.01%)

At close: Aug 15, 2025, 3:59 PM

36.87

-0.03%

After-hours: Aug 15, 2025, 04:10 PM EDT

Harmony Biosciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	200.49M	184.73M	201.27M	186.04M	172.81M	154.62M	168.41M	160.27M	134.22M	119.13M	128.31M	117.21M	107.03M	85.31M	91.21M	80.73M	73.82M	59.67M
Cost of Revenue	38.15M	31.99M	54.41M	42.78M	38.1M	33.45M	43.15M	32.3M	25.01M	20.78M	26.89M	22.96M	18.92M	14.72M	17.82M	14.6M	12.69M	10.41M
Gross Profit	162.34M	152.74M	146.86M	143.26M	134.71M	121.17M	125.26M	127.97M	109.21M	98.35M	101.42M	94.25M	88.11M	70.6M	73.4M	66.13M	61.13M	49.27M
Operating Income	48.18M	56.24M	55.73M	61.71M	21.36M	52.03M	40.2M	64.51M	46.9M	40.42M	47.61M	11.9M	33.12M	27.56M	28.63M	21.05M	23.31M	14.53M
Interest Income	5.3M	5.04M	4.48M	4.93M	4.71M	4.43M	4.1M	4.11M	3.44M	3.09M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	49.64M	57.18M	56.16M	62.17M	21.69M	51.78M	39.69M	51.83M	44.09M	37.78M	44.1M	7.97M	29.23M	23.39M	24.48M	-10.52M	16.09M	7.39M
Net Income	39.78M	45.56M	49.48M	46.09M	11.59M	38.33M	26.61M	38.46M	34.3M	29.48M	48.51M	87.94M	23.53M	21.48M	22.71M	-9.62M	14.12M	7.39M
Selling & General & Admin	64M	61.95M	56.47M	56.16M	55.73M	52.91M	54.76M	45.96M	47.34M	44.63M	43.72M	41.8M	42.32M	35.46M	37.31M	33.34M	31.32M	30.05M
Research & Development	50.16M	34.54M	34.67M	25.39M	63.58M	22.19M	30.31M	17.5M	14.97M	13.29M	10.09M	40.55M	12.67M	7.58M	7.45M	11.74M	6.5M	4.68M
Other Expenses	n/a	n/a	n/a	n/a	37K	-141K	193K	-5K	-31K	2K	73K	56K	42K	-2K	31K	n/a	4K	-20K
Operating Expenses	114.16M	96.49M	91.13M	81.55M	113.35M	69.14M	85.06M	63.46M	62.31M	57.92M	53.81M	82.35M	54.99M	43.04M	44.77M	45.08M	37.82M	34.73M
Interest Expense	3.65M	-3.84M	4.21M	4.35M	4.4M	4.54M	4.8M	7.01M	6.22M	5.73M	3.58M	3.99M	3.93M	4.17M	4.19M	5.43M	7.23M	7.13M
Selling & Marketing Expenses	30.07M	30.71M	27.6M	27.58M	28.51M	27.23M	26.89M	23.42M	24.53M	22.57M	21.07M	20.47M	20.16M	17.58M	19.11M	16.48M	17.02M	15.51M
Cost & Expenses	152.31M	128.49M	145.54M	124.33M	151.46M	102.58M	128.22M	95.76M	87.31M	78.7M	80.69M	105.31M	73.91M	57.76M	62.58M	59.68M	50.51M	45.14M
Income Tax Expense	9.86M	-11.62M	6.68M	16.08M	10.1M	13.45M	13.08M	13.37M	9.79M	8.29M	-4.41M	-79.98M	5.7M	1.9M	1.76M	-902K	1.97M	n/a
Shares Outstanding (Basic)	57.47M	57.31M	57.1M	56.87M	56.8M	56.77M	58.32M	59.86M	59.97M	59.73M	59.48M	59.23M	59.06M	58.91M	58.55M	56.59M	56.94M	56.89M
Shares Outstanding (Diluted)	58.43M	58.52M	58.22M	58.1M	57.54M	57.6M	58.85M	60.68M	60.74M	61.22M	61.62M	61.21M	60.92M	60.59M	60.31M	57.72M	58.59M	58.81M
EPS (Basic)	0.69	0.79	0.87	0.81	0.20	0.68	0.46	0.64	0.57	0.49	0.82	1.48	0.40	0.36	0.39	-0.17	0.25	0.13
EPS (Diluted)	0.68	0.78	0.85	0.79	0.20	0.67	0.45	0.63	0.56	0.48	0.79	1.44	0.39	0.35	0.38	-0.17	0.24	0.13
EBITDA	59.25M	66.98M	66.33M	72.49M	27.41M	58.16M	46.32M	70.61M	52.97M	46.49M	53.68M	17.96M	39.17M	32.76M	33.39M	-361K	28.04M	19.21M
EBIT	53.28M	61.01M	60.36M	66.52M	21.36M	52.03M	55.12M	64.51M	46.9M	40.42M	47.69M	11.96M	33.16M	27.55M	2.5M	-5.09M	23.32M	14.53M
Depreciation & Amortization	5.97M	5.97M	5.97M	5.97M	6.05M	6.12M	6.13M	6.11M	6.06M	6.06M	6.07M	6.06M	6.05M	5.2M	4.76M	4.67M	4.73M	4.68M